This case report highlights a successful management strategy using corticosteroids, tocilizumab, and experimental AT-001 for severe COVID-19-related myocarditis and ARDS.
Answers are grounded in this paper and cite their sources.
May inform refractory COVID-19 myocarditis management; leaves open efficacy without controlled trials.
We describes a case of a critically ill patient with myocarditis and severe acute respiratory distress syndrome related to coronavirus disease-2019. This case highlights management strategies, including the use of corticosteroids, an interleukin-6 inhibitor, and an aldose reductase inhibitor, resulting in complete clinical recovery. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Coyle et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: